Stock screenerAll disclosures →
EDGAR →
MGTX
Conviction 81HealthcareScan · Fri, Jun 26, 2026MGTX$12.08+4.73%
ResistanceSupportVol 14Insider sellVol MA14 929.89K
Mar 27Apr 15May 4May 20Jun 9Jun 26
Price12.08
Change+4.73%
Gap-0.26%
Rel volume1.06×
Avg volume930.74K
Avg $ vol9.83M
SMA 2010.20
SMA 509.86
SMA 2008.52
Price vs 50+22.51%
Price vs 200+41.81%
MA stackbullish
50/200 cross—
Supertrendup · 9.95
RSI (14)72
MACD hist0.24
MACD crossbull · 7d
Stoch %K / %D94 / 84
ADX (14)28
+DI / −DI29 / 9
RSI divergence—
MACD divergenceBullish
ATR %+5.30%
ADR %6.18%
52w high12.08
52w low6.48
From 52w high+0.00%
Above 52w low+86.34%
New 52w highYes
SqueezeOff
Bollinger width40.25%
%B0.96
Donchian pos93.95%
Donchian high12.28
Donchian low8.89
AVWAP (52w high)11.82
vs AVWAP high+2.12%
AVWAP (52w low)8.75
vs AVWAP low+37.98%
OBV trendUp
Chaikin MF (20)0.04
Today vs 20d1.06×
Avg vol (14d)929.89K
Avg vol (20d)930.74K
Avg $ vol (20d)9.83M
Market cap—
RS 3m (vs SPY)+39.52%
RS 6m (vs SPY)+31.69%
RS line new highNo
Trend template8/8
Technical rank91.6
1 week+6.67%
1 month+22.09%
3 months+60.36%
6 months+53.43%
1 year+84.63%
YTD+54.61%
P/E-9.35
P/B-18.38
P/S67.10
P/FCF-21.29
EPS-1.42
Div yield—
ROE196.46%
ROA-46.68%
Debt/Eq—
Current0.55
EV/EBITDA-10.67
Gross margin—
Net margin-717.34%
Rev growth-57.77%
EPS growth22.73%
Price target24.00
Target upside108.06%
Analyst ratingBuy
Institutional73.38%
Ent. value996.71M
Revenue5.1M
Net income-46.31M
Gross profit—
Free cash flow-50.19M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out92.61M
Employees409
ListedFri, Jun 8, 2018
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeA
Conviction81 / 100
Pattern quality—
Tech rank91.6 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance11.50
Support8.92
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in MGTX
No recent disclosed trades by Congress in MGTX. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in MGTX · 5 buys · 4 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Harris Keith R. Director · Ordinary Shares · 2026-06-10 | Exercise | 75K | — | 2026-06-10 | 2026-06-10 |
Harris Keith R. Director · Restricted Share Units · 2026-06-10 | Exercise | 75K | $0 | 2026-06-10 | 2026-06-10 |
Giroux Richard CFO & COO · Ordinary Shares · 2026-05-27 | Other | — | — | 2026-05-27 | 2026-05-28 |
Giroux Richard CFO & COO · Ordinary Shares · 2026-05-27 | Gift | 7K | $0 | 2026-05-27 | 2026-05-28 |
Forbes Alexandria PRESIDENT & CEO · Ordinary Shares · 2026-05-19 | Sell | 62K | $569K | 2026-05-19 | 2026-05-19 |
Fleck Penny Renee CHIEF DEVELOPMENT OFFICER · Stock Option (Right to Buy) · 2026-05-13 | Grant | 100K | $0 | 2026-05-13 | 2026-05-14 |
Fleck Penny Renee CHIEF DEVELOPMENT OFFICER · Restricted Share Units · 2026-05-13 | Grant | 100K | $0 | 2026-05-13 | 2026-05-14 |
Zeldin Robert K CHIEF MEDICAL OFFICER · Ordinary Shares · 2026-01-07 | Tax | 7.81K | $60K | 2026-01-07 | 2026-04-28 |
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Director · Ordinary Shares · 2026-04-17 | Grant | 555.55K | $5.0M | 2026-04-17 | 2026-04-23 |
EDELMAN JOSEPH Director · Ordinary Shares · 2026-04-17 | Grant | 555.55K | $5.0M | 2026-04-17 | 2026-04-23 |
SEC filings
EDGAR filings in MGTX · 1 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.